| HOME >> MEDICINE >> TECHNOLOGY |
2,587$
670$
1,965$
3,257$
2,944Net income per share:Basic$
0.08$
0.02$
0.06$
0.10$
0.09Diluted$
0.08$
0.02$
0.06$
0.10$
0.09Weighted average shares outstanding:Basic33,00333,18432,56733,09332,388Diluted33,98134,09833,45234,03933,303Omnicell, Inc.Condensed Consolidated Balance Sheets(In thousands)June 30,December 31,20112010(unaudited)(1)ASSETSCurrent assets:Cash and cash equivalents$
181,258$
175,635Short-term investments—8,074Accounts receivable, net43,10542,732Inventories17,3829,785Prepaid expenses10,56811,959Deferred tax assets13,05213,052Other current assets5,9407,266Total current assets271,305268,503Property and equipment, net16,32014,351Non-current net investment in sales-type leases8,9139,224Goodwill28,54328,543Other intangible assets4,4144,672Non-current deferred tax assets10,0579,566Other assets9,9018,365Total assets$
349,453$
343,224LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable$
14,380$
13,242Accrued compensation8,1227,731Accrued liabilities6,2248,684Deferred service revenue18,71716,788Deferred gross profit11,30011,719Total current liabilities58,74358,164Long-term deferred service revenue18,85519,171Other long-term liabilities625675Total liabilities78,22378,010Stockholders' equity:Total stockholders' equity271,230265,214Total liabilities and stockholders' equity$
349,453$
343,224(1)
Inform
'/>"/>
| SOURCE Omnicell, Inc. Copyright©2010 PR Newswire. All rights reserved |